You're Invited to be part of the 2nd Brain Health Conference
SUBMISSION DEADLINE:
Tuesday, 30th June 2026
SESSION TOPICS & PROPOSED TITLES
TIME-CRITICAL NEUROLOGY: SAVING THE BRAIN IN THE FIRST HOUR
AHA/ ASA Stroke Guidelines Update
Intracerebral Hemorrhage: Who Truly Benefits from Surgery?
Status Epilepticus: An Understanding to Better Management
Neuromuscular Emergencies: A Safe Approach
HEADACHE & FACIAL PAIN IN THE CGRP ERA
Subarachnoid Hemorrhage
Migraine
Trigeminal Neuralgia & TACs: Practical Management Algorithms
NEURODEGENERATION & BRAIN AGING
Dementia Subtypes in Clinical Practice: Recognizing the Patterns
Alzheimer’s Disease: From Biomarkers to Disease Modification
PRECISION NEUROLOGY & PERSONALISED BRAIN HEALTH
Precision Genomics: Translating Genetic Insights into Lifestyle Action
Personalized Neuro-Rehabilitation After Brain Injury: A Multidisciplinary Approach
NEUROIMMUNOLOGY & MULTIPLE SCLEROSIS: FROM ESCALATION TO EARLY AGGRESSION
NMOSD: Current Management Lessons from a Real-World Case Scenario
Smoldering MS: Radiology Rebranding or Biological Reality?
Family Planning in MS: Evidence, Ethics & Emerging Data
EPILEPSY: BEYOND SEIZURE CONTROL
Drug-Resistant Epilepsy: When to Escalate, When to Refer
Psychogenic Non-Epileptic Seizures: Diagnosis Without Damage
New Anti-Seizure Medications
MOVEMENT DISORDERS: DRUGS, DEVICES & DECISION-MAKING
Non-Motor Aspects of Parkinson’s Disease
Parkinson’s Disease: Early Management in the Modern Era
Navigating Motor Fluctuations and Dyskinesias in Advanced Parkinson’s Disease
Movement Disorders: A Practical Case-Based Approach
Red Flags for Atypical Parkinsonism
NAVIGATING BULBAR AND CRANIAL NERVE PATHOLOGIES IN CLINICAL PRACTICE
Dietary Management of Dysphasia in the Pediatric Setting
Bells Palsy: From Knowledge to Evidence-based Practice
Expanding the Neurodevelopmental Spectrum of a Rare Xq23 Microdeletion Involving DCX and PAK3
NEUROLOGY FOR THE FAMILY PHYSICIAN: PRACTICAL DECISIONS IN PRIMARY CARE
Headache Red Flags & When to Image
Dizziness Simplified: Peripheral vs Central
Common Cervical & Lumbosacral Radiculopathies
Entrapment Neuropathies of Upper & Lower Limbs
First Seizure: Immediate Management & Referral Pathway
NEURO IMAGING & AI
Stroke Imaging: What We Need to Know
Imaging in Neuroradiological Mental Health Disorders
Network Neuroscience and Neural Engineering
Cracking the Cryptogenic Stroke – Transforming the Unknown into Treatable Disease
NEUROMUSCULAR & RARE NEUROLOGIC DISORDERS: FROM DIAGNOSIS TO TARGETED THERAPY
Approach to Peripheral Neuropathy: What Must not be Missed
Inflammatory Neuropathies: When to Escalate Beyond IVIG
Changing the Course of SOD1 ALS: The Tofersen Era
THE FEMALE BRAIN: BIOLOGICAL NUANCES AND CLINICAL REALITIES
Pregnancy and the Brain: Managing Neurological Emergencies, Eclampsia and Safe Neuromodulation from a GCC Perspective
Women & Substance-Abuse Disorder
Incomplete forms or submissions with missing document copies will not be considered
NOTIFICATION OF ACCEPTANCE:
Within 4 weeks of the submission closing deadline. Subject to NHRA approval
Terms & Conditions
1. LANGUAGE
• All abstracts must be written in English
• All presentations will be in English
• Kindly ensure your content is checked for grammatical and spelling errors
2. REGULATION
• The conference is scientific in nature and is overseen by the National Health Regulatory Authority (NHRA) in the Kingdom of Bahrain
3. TOPICS
• All abstracts ideally should conform to the conference theme topics, the list of which is shown below
• If your abstract doesn’t fit into any of the theme topics, please enter your theme topic in the section provided in the form
• Clinically relevant topics of interest must be chosen
• Additionally, please clearly indicate your theme at the top of your abstract submission
〉 TIME-CRITICAL NEUROLOGY: SAVING THE BRAIN IN THE FIRST HOUR
〉 HEADACHE & FACIAL PAIN IN THE CGRP ERA
〉 NEURODEGENERATION & BRAIN AGING
〉 NEUROIMMUNOLOGY & MULTIPLE SCLEROSIS: FROM ESCALATION TO EARLY AGGRESSION
〉 EPILEPSY: BEYOND SEIZURE CONTROL
〉 MOVEMENT DISORDERS: DRUGS, DEVICES & DECISION-MAKING
〉 NEUROLOGY FOR THE FAMILY PHYSICIAN: PRACTICAL DECISIONS IN PRIMARY CARE
〉 NEURO IMAGING & AI
〉 NEUROMUSCULAR & RARE NEUROLOGIC DISORDERS: FROM DIAGNOSIS TO TARGETED THERAPY
〉 PRECISION NEUROLOGY & PERSONALISED BRAIN HEALTH
〉 THE FEMALE BRAIN: BIOLOGICAL NUANCES AND CLINICAL REALITIES
〉 NAVIGATING BULBAR AND CRANIAL NERVE PATHOLOGIES IN CLINICAL PRACTICE
4. SUBMISSION PROCESS
• All abstracts must be submitted via the online form
• Email, WhatsApp or other means of submission will not be accepted or reviewed
5. DURATION OF PRESENTATION
• The presentation duration will be 20 minutes
• Any change to the presentation duration will be informed to you well in advance
6. PEER REVIEW
• All abstracts will undergo a peer review process handled by the conference Scientific Committee
7. NOTIFICATION OF ACCEPTANCE
• Should your abstract be chosen to be part of the final conference agenda, an email of confirmation as well as an invitation letter will be sent to you within 4 weeks after the submission deadline following the government regulatory authority approval
• We will do our best to inform you in case your submission does not get approved however occasionally due to time or manpower constraints you may not receive an email from us. In this case it means we were unfortunately unable to include you in the upcoming conference
8. SPEAKER REGISTRATION
• All approved speakers are required to respond via email within one week of the confirmation email
• Failure to do so may result in losing the speaking spot
9. FISCAL RESPONSIBILITY
• Acceptance of an abstract does not include any form of financial support, travel grant, accommodation, logistics support or any monetary compensation
• Speakers are advised not to arrange any travel bookings until receipt of the email of confirmation
10. DISCLOSURE
• All speakers are mandatorily required to disclose as part of their presentation that their presentations are free from any commercial bias and that they do not have any financial interests
• A disclosure form identifying commercial relationships for all co-authors must be completed by the submitting author if their abstract has been accepted for publication
11. PRESENTATION CONTENT
• Every speaker is solely responsible for the content of their presentation
• The Scientific Committee will not be held responsible for any omissions or errors in the content of the presentation
12. COMPLIMENTARY REGISTRATION
• All accepted speakers will receive a complimentary registration pass for attendance of the conference
13. SCHEDULE CHANGES
• Despite our best efforts, there is always a possibility of changes in the schedule of the conference, including but not limited to last-minute time and/or date changes due to unforeseen circumstances
• A specific date or time slot cannot be guaranteed
14. RIGHTS & PERMISSION
• Through the act of submission of your abstract, you grant your permission to distribute your presentation to the audience
• Said submission and consequent approval also grants us the right to take photographs and/or videos of you during your presentation and publish them via any media channel including but not limited to social media and print media for marketing purposes
15. PHOTO
• A headshot with a monochromatic, light colour background is required
• Vertical format is preferred
• In case of horizontal format, please ensure there is enough background to enable cropping into the required format
• Images should be of a good resolution and in .jpg / .jpeg / .png format
16. CONTACT
• If more info is required or in case of any queries, please Call / send SMS or WhatsApp on +973 3778 6695
• A reminder that all abstracts must be submitted via the online form only
• Email, WhatsApp or other means of submission will not be accepted or reviewed
17. CME CERTIFICATE
• The CME certificate for the completed speaking session will be issued within 1 week of the end of the conference
• A soft copy of the certificate may be sent via email, if required
ACCREDITED BY